The store will not work correctly when cookies are disabled.
N-(tert-butyl)-2-(pyridin-4-yl)-1,7-naphthyridin-4-amine
ID: ALA4454440
PubChem CID: 135390225
Max Phase: Preclinical
Molecular Formula: C17H18N4
Molecular Weight: 278.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12
Standard InChI: InChI=1S/C17H18N4/c1-17(2,3)21-15-10-14(12-4-7-18-8-5-12)20-16-11-19-9-6-13(15)16/h4-11H,1-3H3,(H,20,21)
Standard InChI Key: OLUIHIBCEWNDET-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
19.1503 -8.4361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4417 -8.8419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1279 -10.8725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4345 -11.2769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7123 -10.8725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7123 -10.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4345 -9.6591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1279 -10.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0230 -9.6591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3007 -10.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3007 -10.8725 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0230 -11.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8502 -11.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5435 -12.5192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8502 -12.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2658 -12.1148 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5435 -10.8725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2650 -11.2695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1602 -7.6224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8548 -8.8501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8561 -8.0233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
3 8 2 0
6 9 1 0
9 10 2 0
10 11 1 0
12 11 2 0
5 12 1 0
3 13 1 0
17 13 2 0
14 16 1 0
15 14 2 0
13 15 1 0
18 16 2 0
17 18 1 0
7 2 1 0
2 1 1 0
1 19 1 0
1 20 1 0
1 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.36 | Molecular Weight (Monoisotopic): 278.1531 | AlogP: 3.90 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.70 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.81 | CX LogP: 2.26 | CX LogD: 2.25 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -0.90 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |